Trial intelligence / Profile preview

Preoperative atropine, glucuronium bromide, and pentylenethyclidine in elderly ESD patients

ChiCTR2300078413Phase 4Recruiting

Sponsor
Affiliated Hospital of North Sichuan Medical College
Start
Dec 2023
Modality
Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of atropine, glycopyrronium and penehyclidine in postoperative delirium (POD), post-operative cognitive decline (POCD) and Delayed postoperative recovery (DPR) (4 arms), sponsored by Affiliated Hospital of North Sichuan Medical College. Primary endpoint: Confusion Assessment Method (CAM) score. Started Dec 2023; status: recruiting.

02

Drugs

atropineglycopyrroniumpenehyclidine
03

Conditions

postoperative delirium (POD)post-operative cognitive decline (POCD)Delayed postoperative recovery (DPR)

Beyond the preview

Go deeper on ChiCTR2300078413.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300078413.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call